Skip to main content
. 2022 Aug 2;8:95. doi: 10.1038/s41531-022-00362-3

Table 3.

Generalized linear mixed analysis for the comparison of the progression over time of clinical variables between de novo Parkinson’s patients with stable weight, weight loss, or weight gain.

Outcome Baseline
(n = 406)
Year 1
(n = 363)
Year 2
(n = 363)
Year 3
(n = 359)
Year 4
(n = 341)
Year 5
(n = 314)
Group × Time effect
Est (SE) p
MDS- UPDRS I
Stable weight 5.4 ± 4.0 6.7 ± 4.7 7.3 ± 4.8 7.8 ± 5.3 8.7 ± 5.7 8.9 ± 5.8
Weight loss 5.7 ± 3.9 7.3 ± 4.7 7.8 ± 5.5 9.1 ± 5.5 9.9 ± 6.7 10.0 ± 7.1 0.22 (0.09) 0.013
Weight gain 5.9 ± 4.4 6.3 ± 4.3 8.0 ± 5.2 8.2 ± 5.7 8.9 ± 4.6 9.7 ± 5.7 0.25 (0.11) 0.026
MDS- UPDRS II
Stable weight 5.5 ± 4.1 7.0 ± 4.9 7.5 ± 5.2 8.1 ± 5.4 9.4 ± 6.6 9.4 ± 5.8
Weight loss 6.2 ± 4.3 8.4 ± 5.2 8.9 ± 5.5 10.3 ± 6.2 10.8 ± 7.2 11.5 ± 7.7 0.32 (0.09) <0.001*
Weight gain 6.3 ± 4.1 7.2 ± 4.4 7.4 ± 4.5 8.0 ± 4.6 9.4 ± 5.8 10.0 ± 5.7 −0.01 (0.1) 0.945
MDS- UPDRS III
Stable weight 19.4 ± 8.2 22.7 ± 9.4 25.2 ± 11.5 27.6 ± 12.3 26.9 ± 11.4 30.6 ± 12.4
Weight loss 22.0 ± 9.2 27.4 ± 10.7 30.1 ± 10.5 33.1 ± 11.4 34.3 ± 12.4 33.7 ± 12.9 0.45 (0.2) 0.854
Weight gain 22.7 ± 9.5 23.7 ± 12.0 27.3 ± 12.8 25.7 ± 11.2 29.5 ± 14.0 29.1 ± 11.8 −0.81 (0.3) <0.001*
MDS- UPDRS IV
Stable weight NA 0.4 ± 1.3 0.7 ± 1.7 1.0 ± 1.8 1.6 ± 2.5 2.1 ± 2.8
Weight loss NA 0.4 ± 1.3 0.9 ± 2.1 1.0 ± 2.2 1.6 ± 2.9 2.0 ± 3.2 −0.003 (0.02) 0.962
Weight gain NA 0.6 ± 1.6 0.3 ± 0.9 0.5 ± 1.3 1.3 ± 2.4 2.4 ± 2.8 0.02 (0.09) 0.696
MDS-UPDRS
Stable weight 30.3 ± 12.5 36.1 ± 14.5 39.4 ± 17.4 42.6 ± 18.1 46.3 ± 17.9 48.0 ± 18.5
Weight loss 33.9 ± 13.1 43.6 ± 16.8 46.9 ± 16.6 52.7 ± 18.8 53.8 ± 22.1 53.8 ± 21.2 1.07 (0.32) 0.001*
Weight gain 34.3 ± 14.5 37.4 ± 16.4 42.8 ± 16.6 41.5 ± 16.6 46.8 ± 20.1 50.0 ± 18.9 −0.40 (0.41) 0.340
ADL
Stable weight 94.0 ± 5.4 91.0 ± 7.0 89.2 ± 8.3 88.4 ± 7.8 86.6 ± 10.3 86.0 ± 10.4
Weight loss 91.9 ± 6.2 89.7 ± 6.3 87.4 ± 8.2 86.0 ± 8.5 83.0 ± 10.3 80.5 ± 16.4 0.07 (0.18) <0.001*
Weight gain 93.4 ± 6.2 91.2 ± 6.3 90.6 ± 6.4 89.5 ± 7.5 88.2 ± 3.7 86.9 ± 8.0 0.27 (0.23) 0.237
MoCA
Stable weight 26.9 ± 2.4 26.4 ± 2.7 26.3 ± 2.9 26.6 ± 2.8 26.8 ± 3.1 27.0 ± 2.9
Weight loss 27.3 ± 2.2 26.3 ± 3.0 26.2 ± 3.6 26.1 ± 3.3 25.7 ± 4.1 25.4 ± 4.6 0.35 (0.05) <0.001*
Weight gain 27.2 ± 2.2 26.1 ± 2.7 26.2 ± 3.2 26.5 ± 3.1 26.5 ± 3.7 27.2 ± 2.7 0.05 (0.06) 0.448
GDS
Stable weight 2.1 ± 2.2 2.3 ± 2.8 2.3 ± 2.6 2.3 ± 2.6 2.5 ± 2.6 2.5 ± 2.6
Weight loss 2.3 ± 2.3 2.7 ± 3.1 2.7 ± 2.9 3.1 ± 3.1 2.8 ± 3.1 3.3 ± 3.2 0.10 (0.05) 0.061
Weight gain 2.8 ± 3.1 2.7 ± 2.7 3.4 ± 3.4 2.7 ± 2.7 2.6 ± 2.8 2.7 ± 2.6 −0.10 (0.06) 0.116
STAI
Stable weight 63.9 ± 18.0 64.1 ± 18.5 62.9 ± 17.4 63.6 ± 17.9 64.2 ± 18.1 63.7 ± 18.1
Weight loss 64.7 ± 17.3 65.7 ± 18.3 67.3 ± 20.1 66.7 ± 20.7 65.7 ± 19.6 67.8 ± 22.7 0.42 (0.30) 0.167
Weight gain 69.7 ± 20.3 68.0 ± 19.5 68.1 ± 19.0 65.3 ± 18.5 65.6 ± 19.1 63.4 ± 16.5 −1.10 (0.39) 0.004*
SCOPA
Stable weight 8.9 ± 5.7 10.5 ± 6.2 10.6 ± 6.3 11.3 ± 6.6 11.8 ± 7.1 12.7 ± 8.1
Weight loss 10.2 ± 6.6 12.3 ± 6.8 12.7 ± 7.0 14.2 ± 7.8 14.2 ± 8.2 15.2 ± 9.0 0.20 (0.10) 0.061
Weight gain 8.8 ± 5.4 9.83 ± 6.0 11.2 ± 5.3 11.8 ± 6.2 12.9 ± 6.0 13.6 ± 5.5 0.18 (0.13) 0.168
ESS
Stable weight 5.5 ± 3.1 6.1 ± 4.1 6.7 ± 4.4 7.2 ± 4.4 7.4 ± 4.5 7.6 ± 4.5
Weight loss 6.4 ± 3.8 6.5 ± 4.0 6.6 ± 4.0 7.6 ± 4.7 7.6 ± 4.8 8.0 ± 4.7 −0.06 (0.08) 0.433
Weight gain 4.8 ± 2.8 5.6 ± 3.5 6.8 ± 4.0 7.0 ± 4.0 7.3 ± 4.8 7.7 ± 5.2 0.18 (0.09) 0.060

NA not applicable, MDS-UPDRS Movement Disorders Society Unified Parkinson Disease Rating Scale, MoCA Montreal Cognitive Assessment. SCOPA-AUT SCOPA-autonomic, UPSIT University of Pennsylvania Smell Identification Test, GDS Geriatric Depression Scale, STAI State-Trait Anxiety Inventory, ESS Epworth Sleepiness Scale.

*Significant p-values after Bonferroni correction for multiple testing.